Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer
Author:
Affiliation:
1. Faculty of Medicine; Department of Medical Oncology; Kyorin University; Tokyo Japan
2. Faculty of Medicine; Department of Pathology; Kyorin University; Tokyo Japan
3. Faculty of Medicine; Department of Surgery; Kyorin University; Tokyo Japan
Publisher
Wiley
Subject
Hepatology,Surgery
Reference35 articles.
1. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial;Oettle;JAMA,2007
2. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer;Ueno;Br J Cancer,2009
3. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial;Neoptolemos;JAMA,2010
4. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01);Uesaka;Lancet,2016
5. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Conversion surgery for initially unresectable locally advanced pancreatic ductal adenocarcinoma after chemotherapy followed by carbon-ion radiotherapy: a case report;Journal of Medical Case Reports;2024-01-11
2. Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer;Cancers;2023-11-25
3. Essential updates 2021/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma;Annals of Gastroenterological Surgery;2023-01-18
4. Design of size uniform and controllable covalent organic framework nanoparticles for high-performance anticancer drug delivery;Journal of Biomaterials Applications;2022-12-06
5. Predicting Early Disease Recurrence of Pancreatic Cancer following Surgery: Determining the Role of NUDT15 as a Prognostic Biomarker;Current Oncology;2022-04-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3